Jena Amit, Shashirekha Govind
Department of Conservative Dentistry and Endodontics, Institute of Dental Sciences, Siksha 'O' Anusandhan University, Bhubaneswar, Odisha, India.
J Conserv Dent. 2013 Mar;16(2):171-4. doi: 10.4103/0972-0707.108209.
The purpose of this prospective, randomized, double-blind, placebo-controlled study was to compare the effect of the administration of preoperative ibuprofen, ketorolac, combination of etodolac with paracetamol and combination of aceclofenac with paracetamol versus placebo for the potential increased effectiveness of the inferior alveolar nerve block [IANB] anesthesia.
A total of 100 endodontic emergency patients in moderate to severe pain diagnosed with irreversible pulpitis of a mandibular posterior tooth randomly received, in a double-blind manner, either a drug or placebo 30 minutes before the administration of a conventional IANB. Cold testing was done before administration of anesthesia to determine level of pain using Heft-Parker Visual Analogue Scale (VAS) score. Success was defined as no pain or pain (VAS) on access or initial instrumentation.
Overall success was 54% for all the groups. Success was highest (70%) for the ketorolac group, 55% for both ibuprofen group and combination of aceclofenac with paracetamol group, 50% for combination of etodolac with paracetamol group, and 40% for the placebo group.
Under the conditions of this study, the use of preoperative medication did improve the anesthetic efficacy of IANB for the treatment of teeth diagnosed with irreversible pulpitis but not significantly.
这项前瞻性、随机、双盲、安慰剂对照研究的目的是比较术前给予布洛芬、酮咯酸、依托度酸与对乙酰氨基酚联合用药以及醋氯芬酸与对乙酰氨基酚联合用药相对于安慰剂对下牙槽神经阻滞(IANB)麻醉潜在增强效果的影响。
总共100例诊断为下颌后牙不可逆性牙髓炎且疼痛为中度至重度的牙髓病急症患者,在进行常规IANB麻醉前30分钟,以双盲方式随机接受一种药物或安慰剂。在麻醉给药前进行冷测试,使用赫夫特 - 帕克视觉模拟量表(VAS)评分来确定疼痛程度。成功定义为在开髓或初次器械操作时无疼痛或疼痛(VAS)评分低。
所有组的总体成功率为54%。酮咯酸组的成功率最高(70%),布洛芬组和醋氯芬酸与对乙酰氨基酚联合用药组均为55%,依托度酸与对乙酰氨基酚联合用药组为50%,安慰剂组为40%。
在本研究条件下,术前用药确实提高了IANB对诊断为不可逆性牙髓炎牙齿的麻醉效果,但效果不显著。